Mira Pharmaceuticals (MIRA) Non-Current Assets (2022 - 2025)

Mira Pharmaceuticals has disclosed Non-Current Assets across 4 years of filings, most recently posting $35439.0 for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $35439.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $141756.0 (down 40.9% YoY), and the FY2025 annual result was $35439.0, changed 0.0% from the prior year.
• Non-Current Assets came in at $35439.0 for Q4 2025 at Mira Pharmaceuticals, roughly flat from $35439.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3.4 million in Q2 2023 to a low of $35439.0 in Q3 2024.
• The 4-year median for Non-Current Assets is $35439.0 (2024), against an average of $645159.8.
• Across the five-year window, Non-Current Assets sank 98.8% in 2024 and changed 0.0% in 2025, its largest moves.
• Mira Pharmaceuticals' Non-Current Assets stood at $363669.0 in 2022, then sank by 79.59% to $74213.0 in 2023, then slumped by 52.25% to $35439.0 in 2024, then changed by 0.0% to $35439.0 in 2025.
• The last three Non-Current Assets figures came in at $35439.0 (Q4 2025), $35439.0 (Q3 2025), and $35439.0 (Q2 2025), per Business Quant data.